Graphene Investments Sas Jazz Pharmaceuticals PLC Transaction History
Graphene Investments Sas
- $145 Billion
- Q4 2024
A detailed history of Graphene Investments Sas transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Graphene Investments Sas holds 24,200 shares of JAZZ stock, worth $3 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
24,200
Previous 27,000
10.37%
Holding current value
$3 Million
Previous $3.01 Billion
0.93%
% of portfolio
2.06%
Previous 1.93%
Shares
5 transactions
Others Institutions Holding JAZZ
# of Institutions
543Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$763 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$749 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$314 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$275 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$253 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.78B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...